As of 2025-10-30, the Relative Valuation of Antares Pharma Inc (ATRS) is 6.92 USD. This relative valuation is based on P/E multiples. With the latest stock price at 5.59 USD, the upside of Antares Pharma Inc based on Relative Valuation is 23.7%.
The range of the Relative Valuation is 5.83 - 8.37 USD.
| Range | Selected | |
| Trailing P/E multiples | - | - |
| Forward P/E multiples | 17.5x - 25.1x | 20.8x |
| Fair Price | 5.83 - 8.37 | 6.92 |
| Upside | 4.4% - 49.8% | 23.7% |
| Date | P/E |